Implications of non-prescription antibiotic sales in China

Aubrey Kalungia, Brian Godman

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
3 Downloads (Pure)


The Article by Jie Chang and colleagues published in The Lancet Infectious Diseases1 is very timely. It reflects a crucial need for concerted efforts to reduce irrational use of antibiotics to lower rising antimicrobial resistance.2, 3, 4 Overuse has resulted in antibiotics becoming the most commonly used drugs globally.3, 5 Antimicrobial resistance increases morbidity, mortality, and costs because health systems run out of options to treat common infectious diseases.1, 2, 6, 7 Low-income and middle-income countries (LMICs), including China, are a particular concern given their increasing overuse of antibiotics8 coupled with a greater effect of antimicrobial resistance than in high-income countries, because of living conditions, including poor sanitation, malnutrition, and high population density.
Original languageEnglish
Pages (from-to)1272-1273
Number of pages2
JournalLancet Infectious Diseases
Issue number12
Early online date3 Oct 2019
Publication statusPublished - 31 Dec 2019


  • antibiotic overuse
  • nonprescription antibiotics
  • China

Cite this